Request Demo
Last update 16 May 2025
Amlodipine Besylate/Tadalafil
Last update 16 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms HCP 1302, HCP-1302, HCP1302 + [1] |
Target |
Action inhibitors, blockers |
Mechanism PDE5A inhibitors(Phosphodiesterase 5A inhibitors), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (03 May 2016), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC22H19N3O4 |
InChIKeyWOXKDUGGOYFFRN-IIBYNOLFSA-N |
CAS Registry171596-29-5 |
View All Structures (2)
Related
1
Clinical Trials associated with Amlodipine Besylate/TadalafilNCT02587988
A Randomized, Double-blind, Multicenter, Phase Ⅲ Study to Evaluate the Efficacy and Safety of HCP1302 in Both Erectile Dysfunction and Hypertension Patients Being Treated With HGP0904
100 Clinical Results associated with Amlodipine Besylate/Tadalafil
Login to view more data
100 Translational Medicine associated with Amlodipine Besylate/Tadalafil
Login to view more data
100 Patents (Medical) associated with Amlodipine Besylate/Tadalafil
Login to view more data
100 Deals associated with Amlodipine Besylate/Tadalafil
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Erectile Dysfunction | South Korea | 03 May 2016 | |
| Hypertension | South Korea | 03 May 2016 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free